{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:33:32Z","timestamp":1790267612812,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001862","name":"The Swedish Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.psyneuen.2016.11.033","type":"journal-article","created":{"date-parts":[[2016,11,29]],"date-time":"2016-11-29T13:48:05Z","timestamp":1480427285000},"page":"135-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":150,"special_numbering":"C","title":["Combined oral contraceptive use is associated with both improvement and worsening of mood in the different phases of the treatment cycle\u2014A double-blind, placebo-controlled randomized trial"],"prefix":"10.1016","volume":"76","author":[{"given":"Cecilia","family":"Lundin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina Gemzell","family":"Danielsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Bixo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Moby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Bengtsdotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabella","family":"Jawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Marions","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Brynhildsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agota","family":"Malmborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingela","family":"Lindh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger","family":"Sundstr\u00f6m Poromaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2016.11.033_bib0005","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0306-4530(93)90053-N","article-title":"Oral contraceptives and the dexamethasone suppression test","volume":"18","author":"Ansseau","year":"1993","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0010","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.psyneuen.2008.01.007","article-title":"Patients with adverse mood effects from combined oral contraceptives have lower levels of prepulse inhibition than healthy controls","volume":"33","author":"Borgstrom","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0015","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s002130100810","article-title":"Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies","volume":"156","author":"Braff","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0020","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.psyneuen.2009.01.003","article-title":"Adolescents' cortisol responses to awakening and social stress; effects of gender, menstrual phase and oral contraceptives. The TRAILS study","volume":"34","author":"Bouma","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0025","article-title":"Toward the reliable diagnosis of DSM-5 premenstrual dysphoric disorder: the Carolina Premenstrual Assessment Scoring System (C-PASS)","author":"Eisenlohr-Moul","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00737-005-0103-y","article-title":"Daily Record of Severity of Problems (DRSP): reliability and validity","volume":"9","author":"Endicott","year":"2006","journal-title":"Arch. Womens Ment. Health"},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0035","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.neuroscience.2009.06.052","article-title":"Gender and the use of hormonal contraception in women are not associated with cerebral cortical 5-HT 2A receptor binding","volume":"163","author":"Frokjaer","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0040","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.psyneuen.2012.11.006","article-title":"Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill-a double-blinded, placebo-controlled randomized trial of a levonorgestrel-containing combined oral contraceptive","volume":"38","author":"Gingnell","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0045","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.biopsych.2012.09.018","article-title":"Blockade of estrogen by hormonal contraceptives impairs fear extinction in female rats and women","volume":"73","author":"Graham","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0050","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0010-7824(95)00226-X","article-title":"The effects of steroidal contraceptives on the well-being and sexuality of women: a double-blind, placebo-controlled, two-centre study of combined and progestogen-only methods","volume":"52","author":"Graham","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0055","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0002-9378(03)00927-X","article-title":"Impact of oral contraceptive pill use on premenstrual mood: predictors of improvement and deterioration","volume":"189","author":"Joffe","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0060","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0306-4530(94)00078-O","article-title":"Preliminary evidence for reduced cortisol responsivity to psychological stress in women using oral contraceptive medication","volume":"20","author":"Kirschbaum","year":"1995","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0065","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00213-005-0143-z","article-title":"Cortisol and memory retrieval in women: influence of menstrual cycle and oral contraceptives","volume":"183","author":"Kuhlmann","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0070","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1479-828X.1978.tb00048.x","article-title":"The effects on sexual response and mood after sterilization of women taking long-term oral contraception: results of a double-blind cross-over study","volume":"18","author":"Leeton","year":"1978","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0075","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.contraception.2009.01.019","article-title":"Contraceptive use and pregnancy outcome in three generations of Swedish female teenagers from the same urban population","volume":"80","author":"Lindh","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0080","first-page":"CD006586","article-title":"Oral contraceptives containing drospirenone for premenstrual syndrome","volume":"2","author":"Lopez","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0085","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0022-3999(92)90028-Z","article-title":"Disturbances in dexamethasone suppression test and lower availability of L-tryptophan and tyrosine in early puerperium and in women under contraceptive therapy","volume":"36","author":"Maes","year":"1992","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0090","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3109\/13625187.2011.614029","article-title":"Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17beta-oestradiol in a 24\/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21\/7 regimen","volume":"16","author":"Mansour","year":"2011","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0095","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/scan\/nss128","article-title":"Hormonal contraceptives, menstrual cycle and brain response to faces","volume":"9","author":"Mareckova","year":"2014","journal-title":"Soc. Cogn. Affect. Neurosci."},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0100","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.nlm.2011.06.013","article-title":"Hormonal contraception usage is associated with altered memory for an emotional story","volume":"96","author":"Nielsen","year":"2011","journal-title":"Neurobiol. Learn Mem."},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0105","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.biopsycho.2012.10.007","article-title":"Hormonal contraception use alters stress responses and emotional memory","volume":"92","author":"Nielsen","year":"2013","journal-title":"Biol. Psychol."},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0110","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.contraception.2006.09.008","article-title":"Oral contraceptives: side effects and depression in adolescent girls","volume":"75","author":"O\u2019Connell","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0115","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.fertnstert.2003.08.030","article-title":"Psychological effect of the oral contraceptive formulation containing 3 mg of drospirenone plus 30 microg of ethinyl estradio","volume":"81","author":"Paoletti","year":"2004","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0120","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.contraception.2005.08.021","article-title":"Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation","volume":"72","author":"Pearlstein","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0125","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1093\/scan\/nsv010","article-title":"Amygdala reactivity to negative stimuli is influenced by oral contraceptive use","volume":"10","author":"Petersen","year":"2015","journal-title":"Soc. Cogn. Affect. Neurosci."},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0130","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1600-0412.2011.01333.x","article-title":"Adverse mood symptoms with oral contraceptives","volume":"91","author":"Poromaa","year":"2012","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0135","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.pbb.2006.06.008","article-title":"Oral contraceptives and neuroactive steroids","volume":"84","author":"Rapkin","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0140","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.contraception.2008.08.001","article-title":"Prevalence of psychiatric disorders and premenstrual dysphoric symptoms in patients with experience of adverse mood during treatment with combined oral contraceptives","volume":"79","author":"Segebladh","year":"2009","journal-title":"Contraception"},{"issue":"Suppl. 20","key":"10.1016\/j.psyneuen.2016.11.033_bib0145","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0150","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/jamapsychiatry.2016.2387","article-title":"Association of hormonal contraception with depression","volume":"73","author":"Skovlund","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0155","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s40266-013-0100-1","article-title":"Depression in peri- and postmenopausal women: prevalence, pathophysiology and pharmacological management","volume":"30","author":"Soares","year":"2013","journal-title":"Drugs Aging"},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0160","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0015-0282(99)00205-8","article-title":"Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 microg) and ethinyl estradiol (15 microg) on ovarian activity","volume":"72","author":"Sullivan","year":"1999","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0165","first-page":"380","article-title":"Menstrual cycle influence on cognitive function and emotion processing-from a reproductive perspective","volume":"8","author":"Sundstrom Poromaa","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0170","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1192\/bjp.146.1.45","article-title":"Oral contraception and serious psychiatric illness: absence of an association","volume":"146","author":"Vessey","year":"1985","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0175","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0165-1781(88)90031-5","article-title":"Up-regulatory effect of triphasic oral contraceptive on platelet 3H-imipramine binding sites","volume":"23","author":"Weizman","year":"1988","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0180","first-page":"1","article-title":"Comparative analysis of the effects of nomegestrol acetate \/17 beta-estradiol and drospirenone\/ethinylestradiol on premenstrual and menstrual symptoms and dysmenorrhea","author":"Witjes","year":"2015","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"key":"10.1016\/j.psyneuen.2016.11.033_bib0185","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/01.AOG.0000175834.77215.2e","article-title":"Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder","volume":"106","author":"Yonkers","year":"2005","journal-title":"Obstet. Gynecol."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453016309635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453016309635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:55:41Z","timestamp":1759683341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453016309635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":37,"alternative-id":["S0306453016309635"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2016.11.033","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727084149.793547606","asserted-by":"object"}]},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined oral contraceptive use is associated with both improvement and worsening of mood in the different phases of the treatment cycle\u2014A double-blind, placebo-controlled randomized trial","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2016.11.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}